SO

Sofinnova Partners

VC
Paris, France (US office: San Francisco, CA)Website
How to approach: warm intro preferred
Stage

Seed, Series A

Check Size

$500K – $15.0M

AUM

$4.4B

Portfolio

143+ companies

Team

11 partners

Investor activity
Investments in last 12 months: 0

Investment Thesis

Sofinnova invests in early-stage companies in therapeutic innovation, particularly biotech and immuno-oncology.

Meet the Team

BL

Bommy Lee

Director of Communications

PP

Paola Pozzi

Partner

PP

Paola Pizzi

Director of Operations

JA

Joe Anderson

Partner

GB

Guillaume Baxter

Partner

MC

Matthieu Coutet

Partner

KN

Karl Naegler

Partner

EK

Edward Kliphuis

Partner

GS

Graziano Seghezzi

Managing Partner

AP

Antoine Papiernik

Managing Partner

Biotech
Oncology
Cell Therapy
HR

Henrijette Richter

Managing Partner

Industry Focus

Invests In

Healthcare
Other

Portfolio Companies (143)

Other

CO

Corvidia Therapeutics

Immunotherapy
OR

Orchard Therapeutics

Gene Therapy
AD

Advanced Perfusion Diagnostics

"Discovered via portfolio_page (high confidence)"

SO

Sofinnova Capital XI SCSP SICAV-RAIF (CIK 0002035776)

"Discovered via sec_edgar_form_d (high confidence)"

SEC Form D filing mentioning Sofinnova Partners

CE

CERENIS THERAPEUTICS HOLDING S.A. (CIK 0001637994)

"Discovered via sec_edgar_form_d (high confidence)"

SEC Form D filing mentioning Sofinnova Partners

AA

AAVantgarde Bio

"Discovered via portfolio_page (high confidence)"

AB

ABIONYX Pharma

"Discovered via portfolio_page (high confidence)"

AB

Abivax

"Discovered via portfolio_page (high confidence)"

AB

Ablynx NV

"Discovered via portfolio_page (high confidence)"

AC

Actithera

"Discovered via portfolio_page (high confidence)"

Browse More Investors

Frequently Asked Questions

See if Sofinnova Partners is a match for your startup

Upload your pitch deck to see how well you match with Sofinnova Partners and 200+ other VC firms.